Concepedia

Michał Abram

MA

Statistics

Publications

15

Citations

325

H-Index

12

Active since

2015

Affiliations

Jagiellonian University(Current)

Medicina

Medical University of Warsaw

Instytut Medycyny Wsi im. Witolda Chodźki

Medical University of Lublin

Michał Abram is an author at Jagiellonian University specializing in pharmacology, neuropharmacology, and medicinal chemistry.

ORCID

Publications per year

2015–2023

15

Publications

15

KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization

Katarzyna Socała, Szczepan Mogilski, Mateusz Pieróg et al. · ACS Chemical Neuroscience · 2018 · 48 citations · Full text

, , +14

Multifunctional Hybrid Compounds Derived from 2-(2,5-Dioxopyrrolidin-1-yl)-3-methoxypropanamides with Anticonvulsant and Antinociceptive Properties

Michał Abram, Mirosław Zagaja, Szczepan Mogilski et al. · Journal of Medicinal Chemistry · 2017 · 39 citations · Full text

, , +13

Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents

Michał Abram, Anna Rapacz, Szczepan Mogilski et al. · ACS Chemical Neuroscience · 2020 · 30 citations · Full text

, , +13

N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug

Krzysztof Kamiński, Katarzyna Socała, Mirosław Zagaja et al. · Neurotherapeutics · 2019 · 27 citations · Full text

, , +15

New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones

Krzysztof Kamiński, Mirosław Zagaja, Anna Rapacz et al. · Bioorganic & Medicinal Chemistry · 2015 · 25 citations · Full text

, , +11

1–5 of 15